120 related articles for article (PubMed ID: 17516844)
1. Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway.
Wenzel K; Daskalow K; Herse F; Seitz S; Zacharias U; Schenk JA; Schulz H; Hubner N; Micheel B; Schlag PM; Osterziel KJ; Ozcelik C; Scherneck S; Jandrig B
Biol Chem; 2007 May; 388(5):489-95. PubMed ID: 17516844
[TBL] [Abstract][Full Text] [Related]
2. Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer.
Li D; Ilnytskyy Y; Kovalchuk A; Khachigian LM; Bronson RT; Wang B; Kovalchuk O
Oncotarget; 2013 Sep; 4(9):1373-87. PubMed ID: 23945289
[TBL] [Abstract][Full Text] [Related]
3. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation.
Jang K; Kim M; Seo HS; Shin I
Oncol Rep; 2010 Sep; 24(3):787-93. PubMed ID: 20664988
[TBL] [Abstract][Full Text] [Related]
4. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
5. KEPI, a PKC-dependent protein phosphatase 1 inhibitor regulated by morphine.
Liu QR; Zhang PW; Zhen Q; Walther D; Wang XB; Uhl GR
J Biol Chem; 2002 Apr; 277(15):13312-20. PubMed ID: 11812771
[TBL] [Abstract][Full Text] [Related]
6. Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer.
Nokin MJ; Bellier J; Durieux F; Peulen O; Rademaker G; Gabriel M; Monseur C; Charloteaux B; Verbeke L; van Laere S; Roncarati P; Herfs M; Lambert C; Scheijen J; Schalkwijk C; Colige A; Caers J; Delvenne P; Turtoi A; Castronovo V; Bellahcène A
Breast Cancer Res; 2019 Jan; 21(1):11. PubMed ID: 30674353
[TBL] [Abstract][Full Text] [Related]
7. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
8. Protease Nexin I is a feedback regulator of EGF/PKC/MAPK/EGR1 signaling in breast cancer cells metastasis and stemness.
Tang T; Zhu Q; Li X; Zhu G; Deng S; Wang Y; Ni L; Chen X; Zhang Y; Xia T; Zen K; Pan Y; Jin L
Cell Death Dis; 2019 Sep; 10(9):649. PubMed ID: 31501409
[TBL] [Abstract][Full Text] [Related]
9. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model.
Weng LP; Smith WM; Brown JL; Eng C
Hum Mol Genet; 2001 Mar; 10(6):605-16. PubMed ID: 11230180
[TBL] [Abstract][Full Text] [Related]
10. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of extracellular signal regulated kinase (ERK) leads to apoptosis inducing factor (AIF) mediated apoptosis in epithelial breast cancer cells: the lack of effect of ERK in p53 mediated copper induced apoptosis.
Ostrakhovitch EA; Cherian MG
J Cell Biochem; 2005 Aug; 95(6):1120-34. PubMed ID: 15880691
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor β and Ras/MEK/ERK signaling regulate the expression level of a novel tumor suppressor Lefty.
Miyata N; Azuma T; Hozawa S; Higuchi H; Yokoyama A; Kabashima A; Igarashi T; Saeki K; Hibi T
Pancreas; 2012 Jul; 41(5):745-52. PubMed ID: 22441145
[TBL] [Abstract][Full Text] [Related]
13. MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway.
Li SQ; Wang ZH; Mi XG; Liu L; Tan Y
IUBMB Life; 2015 Oct; 67(10):768-77. PubMed ID: 26399456
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
15. [Overexpression of HER2/neu downregulates wild p53 protein expression via PI3K and Ras/Raf/MEK/ERK pathways in human breast cancer cells].
Zheng L; Ren JQ; Zhang L; Chen Q; Zhu HG
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):358-62. PubMed ID: 15363324
[TBL] [Abstract][Full Text] [Related]
16. Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways.
Niu G; Carter WB
Cancer Res; 2007 Feb; 67(4):1487-93. PubMed ID: 17308086
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells.
Ahmed KM; Dong S; Fan M; Li JJ
Mol Cancer Res; 2006 Dec; 4(12):945-55. PubMed ID: 17189385
[TBL] [Abstract][Full Text] [Related]
18. PTEN modulates insulin-like growth factor II (IGF-II)-mediated signaling; the protein phosphatase activity of PTEN downregulates IGF-II expression in hepatoma cells.
Kang-Park S; Lee YI; Lee YI
FEBS Lett; 2003 Jun; 545(2-3):203-8. PubMed ID: 12804776
[TBL] [Abstract][Full Text] [Related]
19. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
20. PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer.
Zhou XJ; Wu J; Shi L; Li XX; Zhu L; Sun X; Qian JY; Wang Y; Wei JF; Ding Q
J Exp Clin Cancer Res; 2017 Oct; 36(1):149. PubMed ID: 29052531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
